DLD Asset Management’s Medicines Co MDCO Stock Holding History

DLD Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,275,900	Closed	-$278M	–	128
2019 Q4	$278M	Sell	3,275,900 -35,500	-1%	-$2.37M	15%	2
2019 Q3	$166M	Buy	3,311,400 +393,600	+13%	+$15.7M	8.39%	3
2019 Q2	$106M	Buy	2,917,800 +583,000	+25%	+$19M	4.43%	7
2019 Q1	$65.3M	Buy	2,334,800 +887,800	+61%	+$20.9M	2.4%	13
2018 Q4	$27.7M	Buy	1,447,000 +800,500	+124%	+$18.6M	1.9%	17
2018 Q3	$19.3M	Buy	646,500 +108,000	+20%	+$4.07M	0.96%	29
2018 Q2	$19.8M	Buy	538,500 +374,000	+227%	+$12.2M	1.49%	18
2018 Q1	$5.42M	Buy	+164,500	New	+$5.14M	0.49%	47

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

DLD Asset Management's MDCO Position: Q1 2020 in Review

DLD Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 200,000 shares — an estimated $17M sold.

DLD Asset Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $17M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

DLD Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
DLD Asset Management sold 200,000 Medicines Co shares in Q1 2020, an estimated $17M.
DLD Asset Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
DLD Asset Management's Medicines Co position peaked at $17M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on DLD Asset Management's 13F filing for Q1 2020, filed 14 May 2020.